Skip to main content

Table 1 Characteristics of the subjects

From: Dynamics of microbiota during mechanical ventilation in aspiration pneumonia

Subject

Sex

Primary diagnosisa

Co-morbidities

Interval

I to (A) (h)b

Interval

(A) to (B) (h)c

TD (mm)

TD (long/short)d

FIO2 (%)

Medication

Days

Mortalitye

Vasopressor

Immuno-modulator

Admission to recruitment

ICU stay

Mechanical ventilation

Hospital stay

1

M

Aspiration pneumoniae

CVD, COPD

1

11

29 × 24

1.20

30–50

+

–

33

5

9

76

survive

2

M

Asphyxia

Thyroid cancer, HT

1

2

22 × 18

1.22

35–50

–

–

6

6

5

26

survive

3

F

Drug overdose

Depression

0

3

21 × 18

1.16

30–40

+

–

0

5

4

12

survive

4

M

CPA

DCM, CRF

1

15

23 × 19

1.21

45–60

+

–

0

9

14

14

dead

5

M

Epidural hematoma

DM, HT, LC

1

11

32 × 19

1.68

35–45

–

–

3

11

8

25

survive

6

M

Subarachnoid hemorrhage

–

0.5

12

24 × 20

1.20

35–50

–

–

0

4

4

30

survive

7

M

Drug overdose

Depression

0.5

4

23 × 23

1.00

21–50

–

–

0

2

2

4

survive

8

F

Cerebral hemorrhage

SLE, DM, HT

0.5

74

21 × 20

1.05

30–40

–

–

1

8

23

24

survive

9

M

Heart failure

HF, DM, HT, CKD

0.5

1

22 × 21

1.04

45–80

–

–

0

45

44

50

dead

10

F

Convulsion

Epilepsy

1

3

22 × 20

1.10

25–30

–

–

0

4

3

10

survive

11

M

Convulsion

Epilepsy

1.5

2

22 × 20

1.10

25–30

–

–

0

2

2

16

survive

12

M

Aspiration pneumoniae

COPD

0.5

1

20 × 19

1.05

50–60

–

–

1

15

36

37

survive

13

F

Subarachnoid hemorrhage

–

0.5

11

NA

NA

30

–

–

0

4

2

36

survive

14

F

CPA

HF, CVD

1

3

20 × 19

1.05

35–70

–

–

0

8

12

12

survive

15

F

Cerebral hemorrhage

HT

0.5

1

19 × 18

1.05

35

+

–

0

7

6

55

survive

16

M

Subarachnoid hemorrhage

SAS

0.5

3

19 × 19

1.00

35–90

–

–

0

30

51

96

survive

17

M

CPA

CVD, HF, HT

1

12

26 × 21

1.23

35–50

+

–

0

7

11

11

survive

18

F

Aortic dissection

DM, HT

NA

NA

24 × 17

1.41

45–70

–

–

4

16

16

16

dead

19

M

Aspiration pneumoniae

CVD

2

23

25 × 24

1.04

30–40

–

–

3

25

96

99

survive

20

F

Aspiration pneumoniae

Brainstem dysfunction

1

3

20 × 12

1.66

30–45

–

–

5

23

117

120

survive

21

M

Aspiration pneumoniae

HF, DM, HT

NA

NA

26 × 23

1.13

45–95

+

–

0

13

13

13

survive

22

F

Convulsion

Epilepsy, DM

0.5

11

22 × 18

1.22

40–50

+

–

0

7

7

29

survive

  1. M male, F female, CPA cardiopulmonary arrest, CVD cerebral vascular disease, COPD chronic obstructive pulmonary disease, HT hypertension, DCM dilated cardiomyopathy, CRF chronic renal failure, DM diabetes mellitus, LC liver cirrhosis, SLE systemic lupus erythematosus, HF heart failure, CKD chronic kidney disease, SAS sleep apnea syndrome. aDiagnosis resulted in respiratory failure, bInterval I to (A) = time from tracheal intubation to sample collection (A), cInterval (A) to (B) = interval of collecting sample (A) and (B), (A) = samples collected within 2 h after intubation, (B) = samples collected just before administration of antibiotics, TD = tracheal diameter, dTD (long/short) = the ratio of longest/shortest tracheal diameter. eNone of the cases were died of aspiration pneumonia